KT Corporation
7
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
14%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Mobile App for Heart Failure
Role: collaborator
Smartphone-based Stress Management Intervention for Employees
Role: collaborator
Efficacy of Ubiquitous SR-based Memory Advancement and Rehabilitation Training (U-SMART)
Role: collaborator
KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research
Role: collaborator
Research to Evaluate Efficiency in U-health Solution Service for the Chronic Wound Management
Role: collaborator
Effect of U-Health Service in Stroke Patients
Role: collaborator
Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training
Role: collaborator
All 7 trials loaded